Kymera Therapeutics Inc.

KYMR | NASDAQ

Price Alert Chart Builder DCF Calculator

$121.86

+$4.19 (+3.56%)

Sep 22, 2026, 11:27 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-311.35M	-223.86M	-146.96M	-154.81M	-100.22M	-45.59M
Depreciation & Amortization	8.31M	7.37M	3.57M	2.98M	2.4M	1.76M
Stock-Based Compensation	59.9M	55.01M	43.12M	35.48M	24.97M	5.19M
Other Working Capital	16.29M	-41.48M	25.48M	-37.88M	-71.26M	117.58M
Other Non-Cash Items	-5.02M	-9.06M	-11.8M	889K	5.83M	332K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	1.57M
Change in Working Capital	15.27M	-23.97M	9.25M	-37.62M	-61.92M	124.87M
Operating Cash Flow	-232.89M	-194.5M	-102.83M	-153.09M	-128.95M	88.13M
Capital Expenditures	-1.45M	-12.84M	-34.48M	-2.84M	-1.6M	-9.1M
Cash Acquisitions	n/a	n/a	n/a	-20.52M	5.81M	413.49M
Purchase of Investments	-1.01B	-901.23M	n/a	-445.97M	-456.4M	-529.38M
Sales Maturities Of Investments	479.14M	496M	n/a	469.33M	358.17M	115.89M
Other Investing Acitivies	8.88M	13.98M	174.37M	20.52M	-5.81M	-413.49M
Investing Cash Flow	-521.06M	-404.08M	139.89M	20.52M	-99.84M	-422.59M
Debt Repayment	-1.49M	-1.58M	-76K	-1.13M	-849K	-554K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	13.81M	4.27M	4.3M	8.02M	162K
Financial Cash Flow	990.71M	608.85M	4.19M	153M	250.28M	289.26M
Net Cash Flow	236.76M	10.27M	41.25M	20.43M	21.5M	-45.2M
Free Cash Flow	-234.34M	-207.34M	-137.31M	-155.92M	-130.54M	79.03M
Adj. Free Cash Flow	-294.24M	-262.35M	-180.42M	-191.4M	-155.52M	73.84M
Maintenance CapEx	-1.45M	-12.84M	-8.87M	-2.84M	n/a	n/a
Growth CapEx	n/a	n/a	-25.61M	n/a	-1.6M	-9.1M
Owner Earnings	-234.34M	-207.34M	-111.7M	-155.92M	-128.95M	88.13M